Company / Shareholders' Equity
Annexon, Inc. Shareholders' Equity History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$293.1M
FY2024
5-year range
$231.2M / $344.3M
FY2020-FY2024
Trend
+17.0%
vs FY2023
Sector context
#138 of 215
Health Care
What the data says
At $293M, Annexon, Inc.'s shareholders' equity ranks #138 of 215 in the Health Care sector. Improved from $231M to $293M over the past 2 years.
Based on SEC 10-K filings.
$293M in FY2024 with a 3-year CAGR of +8.1%.
Improved from $231M to $293M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#138 of 215 in Health CareTop 64% of 215This company $293.1M Sector average $2.6B
▼
-88.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +8.1%, indicating consistent growth.
- In FY2024, shareholders' equity increased 17.0% year-over-year.
- Ranks #138 out of 215 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $293.1M | +17.0% |
| FY2023 | $250.6M | +8.4% |
| FY2022 | $231.2M | -0.3% |
| FY2021 | $231.9M | -32.6% |
| FY2020 | $344.3M | +442.7% |
| FY2019 | -$100.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026